Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three ...

Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence ...

March is Colorectal Cancer Awareness Month, and doctors are reminding people that screening can help detect the disease early.

New research links increased risk factors to alcohol consumption, ultra-processed foods and other disruptions to the gut microbiome. The Tampa Bay Times is hosting a free community conversation, in ...

She assumed the changes in her body were due to perimenopause or gut issues, but it was rectal cancer, a disease that's on ...

The gut microbiome at time of surgery may significantly impact recurrence of colorectal cancer.An analysis of nearly 300 ...

The rate of colorectal cancer is increasing among younger Americans and is now the leading cause of cancer deaths in adults ...

Case numbers are increasing for all colorectal cancer cases. The new report showed that 45 percent of new colorectal cancer cases are in adults under 65 - up from 27 percent in 1995. Colorectal cancer ...

Dr. Eric Winer, director of the Yale Cancer Center, said in “younger people in general there’s a higher proportion that have ...

ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, Baystreet.ca News Commentary, The global oncology and cancer drugs market, valued at $167 billion in 2023, is projected to reach $335.2 billion ...

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine bloodwork long before diagnosis.